Wire · opportunities
Edwards Wins FDA Tricuspid Repair Nod, Medtronic Posts Strong Ablation Results, and ...
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 3 November 2026 · Fusion42 review
Edwards Lifesciences received FDA approval for its PASCAL Precision system for tricuspid valve repair, expanding its structural heart portfolio. Medtronic reported strong real-world cardiac ablation results for its Sphere-9 catheter and PulseSelect PFA system, while Stryker expanded its sports medicine portfolio via acquisition.
This Wire brief sits within Fusion42's coverage of Medtech, and 6 sources have reported it between 21 Oct 2026 and 3 Nov 2026.
◆ ◆ The Wire takeaway
You can now pitch Edwards’ tricuspid repair device alongside its replacement system to hospitals managing severe valve disease. Sales teams in cardiology tech should sharpen focus on patient criteria and trial data to win against Abbott’s TriClip.
◆ Coverage
6 sources · first reported 21 Oct 2026 · latest 3 Nov 2026
◆ Related on Wire
◆ Topics